In order to prevent the growth of microorganisms, antimicrobial coatings can be applied to the surface of medical devices. These coatings are utilised is a plethora of medical applications from orthopaedic implants to vascular catheters. Various testing methodologies have been established to evaluate the performance of antimicrobial coatings. In this review, testing methods ranging from cytotoxicity testing to durability and biofilm prevention testing will be discussed.
Implantation of medical devices into the human body presents an opportunity for microbial colonisation. Bacterial adherence to the surface of a medical device may result in the formation of a bacterial biofilm. This is a structured community of bacteria encased within a self-produced matrix, and they are notoriously difficult to treat. They display significantly elevated resistance to antibiotics compared to free-floating cells and can serve as a persistent source of infection. Such infections carry serious clinical consequences. Catheter-associated bloodstream infections or infections at the implantation site of prosthetic joints are among the most common and costly infections globally. Furthermore, coatings that perform well initially but lose efficacy in terms of antimicrobial activity or coating degradation over time presents their own risks. Testing therefore extends beyond efficacy assessments and instead encompasses durability, cytotoxicity, and compliance with regulatory standards such as ISO 22196 and ISO 10993.
Cytotoxicity Testing
Antimicrobial activity must be balanced against biocompatibility. Cytotoxicity testing evaluates the potential of the coating or its degradation products to harm host cells. Testing is conducted in accordance with ISO 10993-5, which describes methods for assessing cytotoxic effects of medical device extracts on cell cultures. The standard extract method involves immersing the device in culture medium and exposing the resulting extract to a cell monolayer. Cell viability is then assessed after a defined incubation period, commonly using the MTT or MTS assay, which measures mitochondrial activity as a proxy for cell survival.
Durability Testing
Durability testing subjects coated samples to conditions representative of device handling and deployment, then reassesses antimicrobial activity. For implantable devices, ageing studies are relevant. Samples are incubated under accelerated ageing conditions which are typically elevated temperature in aqueous media. Subsequently after, antimicrobial efficacy is retested at defined intervals. This provides an estimate of shelf life and in-service performance.
For devices subject to mechanical stress during use, combined durability and efficacy protocols are employed. Samples may be subjected to defined bending, abrasion, or compression before antimicrobial testing. A coating that loses efficacy following mechanical manipulation is a clinical concern, particularly for devices deployed through narrow lumens or positioned under compressive load.
Quantitative Suspension Testing
Quantitative suspension testing measures the reduction in viable bacterial count achieved by a coating under defined conditions. A standardised inoculum is applied directly to the coated surface and held for a specified contact time. At the end of the exposure period, surviving organisms are recovered and enumerated using plate count methods.
Results are expressed as a log reduction in colony-forming units (CFU) relative to an untreated control. A log reduction of ≥3 (99.9% kill) is commonly cited as a threshold for meaningful antimicrobial activity, though acceptance criteria vary by application and regulatory context.
This method is applicable to both eluting and contact-active coatings. ISO 22196 is the primary standard governing this approach for non-porous surfaces and forms the basis for many regulatory submissions.
Biofilm Prevention Testing
Biofilm prevention testing evaluates the ability of a coating to inhibit biofilm formation on the device surface. In a typical protocol, coated and uncoated control samples are exposed to a bacterial suspension under conditions that promote biofilm formation, usually surface contact and defined incubation periods. Following exposure, surfaces are rinsed to remove non-adherent cells. Adherent organisms are then recovered and quantified.
Several approaches exist for quantification. Direct plate counting of recovered cells gives CFU per unit area. Alternatively, staining methods such as crystal violet can be used to assess total biomass, though these do not distinguish between live and dead cells. More advanced methods include confocal laser scanning microscopy (CLSM), which allows visualisation of biofilm architecture, and metabolic activity assays such as the resazurin reduction test, which correlates signal intensity with viable cell number.
Together, these testing methodologies provide a comprehensive assessment of antimicrobial coating efficacy.
At Smart Reactors, we offer a wide range of testing services to ensure your coating is thoroughly evaluated and performs as intended. Whether you are searching for a new coating for your medical device or validating performance ahead of a product launch, our team brings the technical expertise and hands-on experience to deliver the data you need with confidence.
To find out more about our capabilities or to discuss the specific requirements of your coating programme, get in touch with the Smart Reactors team today.
